Javascript must be enabled to continue!
Osteoporosis in primary biliary cirrhosis revisited
View through CrossRef
BACKGROUND
Primary biliary cirrhosis (PBC) is increasingly being diagnosed in the earlier non-cholestatic stages of disease. Accepted wisdom has been that PBC is frequently complicated by osteoporosis. Whether this association holds true for the broader spectrum of PBC patients now recognised has not as yet been studied.
AIMS
To examine the extent to which osteoporosis occurs more commonly in PBC patients than in normal individuals of the same age and sex.
DESIGN
Retrospective review of a large cohort of well characterised PBC patients.
PATIENTS
A total of 272 PBC patients with definite or probable PBC followed up for a mean of 10.1 years (total follow up 2726 patient years) who had at least one bone mineral density measurement (BMD).
RESULTS
In this unselected group of PBC patients, mean Z scores (number of SDs from age and sex matched normal mean values) at the neck of femur (NOF) and lumbar spine (LS) at first BMD measurement (7 (6) years after PBC diagnosis) were −0.1 (1.4) and 0.1 (1.4), respectively. At first BMD measurement, 18 PBC patients had Z scores less than −2.0 and 85 had T scores less than −2.5. No factors predictive of osteoporosis were found in affected patients. A total of 957 BMD measurements were performed (0.35 per patient year of follow up); 220 patients had two or more measurements. No patient went on to develop de novo osteoporosis during follow up. In the 51 patients (who were clinically representative of the whole group) who received no PBC or bone related treatment during follow up, %BMD changes per year at the NOF and LS were −1.6 (3.2) and 0.1 (2.2), respectively. No variance in this “natural” rate of BMD measurement was seen in patients receiving PBC modulating agents (including prednisolone and UDCA) or osteoporosis prophylaxis/therapy. Significant improvement at the LS was seen in patients undergoing liver transplantation.
CONCLUSIONS
Osteoporosis is not a specific complication of PBC.
Title: Osteoporosis in primary biliary cirrhosis revisited
Description:
BACKGROUND
Primary biliary cirrhosis (PBC) is increasingly being diagnosed in the earlier non-cholestatic stages of disease.
Accepted wisdom has been that PBC is frequently complicated by osteoporosis.
Whether this association holds true for the broader spectrum of PBC patients now recognised has not as yet been studied.
AIMS
To examine the extent to which osteoporosis occurs more commonly in PBC patients than in normal individuals of the same age and sex.
DESIGN
Retrospective review of a large cohort of well characterised PBC patients.
PATIENTS
A total of 272 PBC patients with definite or probable PBC followed up for a mean of 10.
1 years (total follow up 2726 patient years) who had at least one bone mineral density measurement (BMD).
RESULTS
In this unselected group of PBC patients, mean Z scores (number of SDs from age and sex matched normal mean values) at the neck of femur (NOF) and lumbar spine (LS) at first BMD measurement (7 (6) years after PBC diagnosis) were −0.
1 (1.
4) and 0.
1 (1.
4), respectively.
At first BMD measurement, 18 PBC patients had Z scores less than −2.
0 and 85 had T scores less than −2.
5.
No factors predictive of osteoporosis were found in affected patients.
A total of 957 BMD measurements were performed (0.
35 per patient year of follow up); 220 patients had two or more measurements.
No patient went on to develop de novo osteoporosis during follow up.
In the 51 patients (who were clinically representative of the whole group) who received no PBC or bone related treatment during follow up, %BMD changes per year at the NOF and LS were −1.
6 (3.
2) and 0.
1 (2.
2), respectively.
No variance in this “natural” rate of BMD measurement was seen in patients receiving PBC modulating agents (including prednisolone and UDCA) or osteoporosis prophylaxis/therapy.
Significant improvement at the LS was seen in patients undergoing liver transplantation.
CONCLUSIONS
Osteoporosis is not a specific complication of PBC.
Related Results
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Underweight Sebagai Faktor Resiko Osteoporosis Pada Lansia
Osteoporosis is a bone disease characterized by decreased bone density. The incidence of osteoporosis increases with age, especially age ≥ 50 years. Research from the International...
Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis
Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis
Previous studies in which quantitative immunofluorescence was used have shown that certain biliary epithelial cells in liver with primary biliary cirrhosis show increased levels of...
109. Clinical Characteristics and Outcomes of Staphylococcus aureus Bacteremia From a Biliary Source
109. Clinical Characteristics and Outcomes of Staphylococcus aureus Bacteremia From a Biliary Source
Abstract
Background
Staphylococcus aureus can cause various types of infection, but involvement of biliary tract is rare. There ...
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
pdf Nestatin-1 Level as Potential Parameters in T2DM with and Without Osteoporosis
In osteoporosis (OP) disease, the strength of bones is decreased, and it is mostly correlated with the loss of bone tissues and destruction of bone micro structure, making the pati...
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study
Background/Objectives: This study investigated the timing of adverse events (AEs) after carbon-ion radiotherapy (CIRT) for hepatocellular carcinoma (HCC) and identified the risk fa...
Sistem Pakar Untuk Penentuan Terapi Pada Penderita Osteoporosis
Sistem Pakar Untuk Penentuan Terapi Pada Penderita Osteoporosis
Abstract - Osteoporosis is a disease caused by loss of bone mass, especially lack of calcium. Treatment of osteoporosis can be done by doing osteoporosis therapy. In the expert sys...
A pooled analysis of the association between sarcopenia and osteoporosis
A pooled analysis of the association between sarcopenia and osteoporosis
Background:
Sarcopenia is a progressive generalized skeletal muscle disorder that causes the accelerated loss of muscle mass and function. Osteoporosis is a systemic co...
Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams
Closing the osteoporosis care gap – Increased osteoporosis awareness among geriatrics and rehabilitation teams
Abstract
Background
A care gap exists between recommendations and practice regarding the diagnosis and treatment of osteoporosis in fracture pati...

